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HISTOCOMPATIBILITY (HLA) typing is primarily used to match kidney
donors with awaiting recipients. However many studies have been carried out to
determine the frequency of the HLA antigens in various diseases.
In this laboratory we have been requested to carry out such studies in several
diseases, e.g. diabetes, ankylosing spondylitis, farmer's lung, Plummer-Vinson
stricture and flax byssinosis. In order to compare the antigen frequencies in these
diseases with those of a normal healthy population we decided to type 200 blood
donors. Obviously there are drawbacks to using blood donors as controls as their
health is better than average and their age is not of either extreme. However,
using blood donors provides a simple way to obtain the blood sample required
for our testing and also gives a cross-section of social status within the population.
One interesting and very important offshoot of this study is that we have 200
tissue-typed blood donors who could, if the need occurred, be used for platelet
transfusion if their type was identical to that of a patient requiring platelets.
MATERIALS AND METHODS
Two hundred blood donors (125 male, 75 female) born in Northern Ireland
were tissue typed for HLA-A and -B locus antigens. The number of blood donors
from each county was proportional to the total population of that county. An
extra 10 ml of blood from suitable donors was taken at the donor sessions into
sodium citrate. The blood donors were typed within one day of bleeding.
A total of 72 Sera defining the following specificities were used:
HLA - A1, A2, A3, A9, A10, All, A28, A29
HLA - B5, B7, B8, B12, B13, B14, B15, B17, B18, BW22, B27, BW35, B.40.
The sera were either supplied by the National Tissue Typing Reference
Laboratory, Bristol, or were sera from our own laboratory which have been
tested for their activity both here and in Bristol. Typing was by a two stage
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* Supported by a grant from the Northern Ireland Kidney Research Fund.microlymphocytotoxicity test at 22°C (Nelson and Middleton 1975) and at least
3 sera were used to define each specificity.
The antigen frequency of the Northern Ireland blood donors was compared
with the antigen frequency in 1,036 blood donors from Bristol, in 342 blood
donors from Glasgow and in 453 blood donors from Eire using a Yates' corrected
chi-squared analysis, with a correction for the number of antigens tested (Grumet
et al, 1971).
The gene frequency of each of the antigens in the Northern Ireland blood
donors was calculated using the formula p=l- (sq. rt.) 1-f where p denotes
the gene frequency and f the frequency of the corresponding antigen.
The tissue types of the Northern Ireland blood donors were analysed to find
out if there were any differences in the antigen frequency due to sex, age or
place of birth. In the latter analysis only blood donors born in Co. Down (n=43),
Co. Antrim (n=48) and Belfast (n=42) were considered, as the number of blood
donors born in Counties Derry, Tyrone, Armagh and Fermanagh were con-
sidered too small for statistical analysis. For the purpose of assessing the effect
of age on HLA antigen frequency we divided the blood donors into two groups,
119 aged 16-35 and 81 aged 36-65.
RESULTS
Table 1 shows the frequency of HLA antigens in blood donors from Northern
Ireland compared with the antigen frequency in blood donors from Bristol,
Glasgow and Eire. Statistical differences at the 5 per cent level were found in
the following antigens HLA - Al,-B7,-B8,-B14 and -B18 with Bristol, -All
with Glasgow and -B12 with Dublin. Only one difference, HLA -B14 in the
comparison with Bristol blood donors, is still significant after multiplying the
initial P value by a factor off 21, the number of comparisons made between the
two populations.
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Frequency of HLA antigens in blood donors from Northern Ireland, Bristol,
Glagow and Eire
N. Ireland Bristol Glasgow Eire
Bl. Donors Bl. DI-,nrs Bl. Donors Bl. Donors
Antigen (n=200) (n=1036) (n=342) (n=453)
No % No % No No
1 86 43 348 33.6a 138 40.4 210 46.4
2 91 45.5 536 51.7 163 47.7 217 47.9
3 53 26.5 265 25.6 78 22.8 97 21.4
9 31 15.5 190 18.3 60 17.5 61 13.5
10 20 10 837 8.4 21 6.1 35 7.7
11 28 14 106 10.2 26 7.6f 55 12.1
28 10 5 38 3.7 31 .1 34 7.5
29 16 8 78 7.5 16 4.7 41 9.1
5 13 6.5 87 8.4 21 6.1 26 5.7
7 67 33.5 265 25.6> 93 27.2 124 27.4
8 69 34.5 260 25.lc 105 30.7 156 34.4
12 54 27 254 23.7 114 33.3 163 36 g
13 5 2.5 45 4.3 15 4.4 9 2
14 30 15 72 7 d 34 9.9 47 10.4
15 9 4.5 50 4.8 29 8.5 31 6.8
17 18 9 79 7.6 26 7.6 46 10.2
1.8 16 8 35 3.4e 19 5.6 34 7.5
22 8 4 55 5.3 13 3.8 16 3.5
27 11 5.5 77 7.4 27 7.9 26 5.7
35 16 8 114 11 29 8.5 54 11.9
40 20 10 116 11.2 30 8.8 39 8.6
Listed below are the chi-squared values greater than 4 when the HLA antigen
frequency of Northern Ireland donors is compared with that of Bristol, Glasgow
and Eire. P values in brackets have been corrected for the number of antigen
frequencies compared.
a.
b.
c.
d.
e.
f.
g.
chi2 =
chi2 =
chi2 -
chi2 -
chi2 =
chi2 =
chi2 =
6.108
4.958
7.115
13.305
7.921
5.067
4.648
p = 0.0129
p = 0.0246
p = 0.0075
p = 0.0004
p = 0.0050
p = 0.0231
p = 0.0294
(0.27)
(0.516)
(0.158)
(0.0084)
(0.105)
(0.485)
(0.617)
173In Table 2, which shows the gene frequencies of HLA antigens in Northern
Ireland blood donors, X1 and X2 indicate the gene frequencies of antigens which
we have not been able to detect.
No significant difference in antigen frequency was found between male and
female donors. The frequency of HLA -AlO differs significantly with the age of
donor. Seventeen blood donors (14.3 per cent) aged 16-35 were HLA -AlO
TABLE 2
Gene frequencies of HLA antigens in
HLA Antigen
Al
A2
A3
A9
AIO
All
A28
A29
Xi
B5
B7
B8
B12
B13
B14
B15
B17
B18
BW22
B27
BW35
B40
X2
200 Northern Ireland Blood donors
Gene frequency
.2450
.2618
.1427
.0808
.0513
.0726
.0253
.0408
0.797
1.0000
.0330
.1845
.1907
.1456
.0126
.0780
.0228
.0461
.0408
.0202
.0279
.0408
.0513
.1057
1.0000
positive compared to three blood donors (3.7 per cent) aged 36-65 (p=0.0257).
There were seven blood donors from Co. Antrim (14.6 per cent) who were HLA
-AlO positive whereas all of the Belfast donorswere HA-AIO negative (p=0.0275).
However these differences are no longer significant after correction for the
number of comparisons made. Detailed tables of the analysis of the Northern
Ireland blood donors on the basis of place of birth, age and sex are available
from the authors.
174DISCUSSION
We have compared the frequency of 21 HLA antigens in Northern Ireland
blood donors with that of blood donors from Bristol, Glasgow and Eire. In the
latter two comparisons only one antigen frequency in each, HLA -All and -B12
respectively, was significant at the 5 per cent level. By definition, out of 20
comparisons, on the average, we would expect one of them to be significant at
the 5 per cent level. When we multiplied the initial P value for the two significant
comparisons by a factor of 21 (the number of camparisons made) we found that
in neither case was it still significant. However in the comparison of HLA antigen
frequency in donors from Northern Ireland with those of Bristol we found that
five antigen frequencies HLA -Al,B7,-B8,-B14 and -B18 differed significantly.
One of these, HLA -B14, was still significant after correction for the number
of comparisons made. These differences are unlikely to be due to the sera which
have been well defined both here and at the National Tissue Typing Reference
Laboratory, Bristol. Our number of blood donors tested (200) is much smaller
than the number tested in Bristol (1,036) and this could be one of the reasons
for the difference in frequencies between the two centres.
Our finding that a blood donor population from Northern Ireland has a very
similar HLA antigen frequency to a blood donor population from Glasgow and
from Eire but varies significantly in five antigens from a Bristol blood donor
TABLE 3
ABO distribution in blood donors from Northern Ireland, Bristol, Glasgow
and Eire
Area Group 0 Group A Group B Group AB
N. Ireland 54.74 32.97 9.65 2.63
Bristol* 43.54 45.22 8.37 2.86
Glasgow* 53.08 32.90 10.87 3.15
Eiret 55.89 30.60 10.89 2.60
population, agrees with the ABO distribution of blood donors from these areas
(see Table 3). Also, although the population of Northern Ireland at the moment
is stable it is made up of two distinct origins - the Irish Gaelic and the Ulster
Scot.
Our results show the necessity of using people born in Northern Ireland as a
control group when examining the HLA antigen frequency of people with a
particular disease. For example, to have used the Bristol blood donor HLA
frequency as controls in our study on patients with a Plummer-Vinson stricture
would have led us to believe that HLA -B8 was significantly more frequent in
the patients than in the controls, whereas this is not the case when we use
controls from Northern Ireland (Middleton et al. 1978).
* Taken from Kopec.
t Taken from Dawson.
175We have compared the variation in HLA antigen frequency in two age groups.
There are no significant differences after correction in the groups suggesting that
although some HLA antigens are associated with disease these effects neutralise
each other in the population. Previous findings have shown that older people
have a larger number of HLA specificities than young people (Gerkin et al.
1974, Bender et al 1973). Like ourselves other recent studies have failed to
confirm this (Albert et al. 1974, Murcurova et al. 1975). In our study the average
number of HLA specificities per person below 36 was 3.387 and the average in
the 36-65 age group was 3.309.
Requests to us for tissue typing relatives of prospective platelet recipients have
recently increased. It is very difficult to obtain a full house match for these
recipients from their relatives. Having a panel of potential platelet donors
should make it easier to obtain a perfect match for these platelet recipients.
SUMMARY
Histocompatibility (HLA) antigen testing of 200 normal donors was per-
formed to provide a baseline for studies on the HLA antigen frequency of
patients with diseases. The results were compared with similar results from
Bristol, Eire and Glasgow. The Belfast HLA antigen frequencies closely
resembled the results from Eire and Glasgow but showed marked differences from
Bristol. This finding corresponds to ABO blood group distribution. Our tissue
typed blood donors can now be used as platelet donors if required.
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